Samsung Biologics Continues to Leverage Digitalization to Optimize Client Experience
Through digital transformation, Samsung Biologics is innovating how they connect with clients, regulatory bodies and industry professionals.
Clinical Trial Materials
- All
- APIs
- Aseptic Processing
- cGMP Manufacture
- Cleaning Validation
- Clinical Trial Materials
- Cytotoxics and High Potency Manufacturing
- Excipients
- Extractables and Leachables
- Facilities
- Fill/Finish
- Lyophilization
- Parenterals
- Process Development
- Process Validation
- Risk Management
- Scale-up/Technology Transfer
- Solid Dosage/Creams/Ointments
-
Aseptic Processing | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Fill/Finish | Industry News
Piramal Inks Clinical Supply Deal with Theratechnologies
CDMO to provide sterile fill/finish drug product formulation and manufacturing from its Lexington, KY facility.Tim Wright, Editor, Contract Pharma 01.21.21
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Industry News | Process Development
Capricor, Lonza Enter CAP-1002 Development Agreement
Lonza will perform process development activities for late-clinical and commercial-scale GMP manufacturing of CAP-1002.Contract Pharma Staff 01.12.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
Akston Biosciences and LakePharma Enter Covid-19 Partnership
Will manufacture second-generation COVID-19 vaccine, AKS-452.Contract Pharma Staff 01.05.21
-
Analytical Services | Biologics, Proteins, Vaccines | Clinical Trial Materials | Laboratory Testing
-
Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Lonza Expands Conjugation Facility in Visp
Two additional manufacturing suites will provide development and manufacturing capacity for preclinical to commercial supply.Contract Pharma Staff 12.21.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Thermo Fisher Expands Plasmid DNA Mfg. Capabilities
New 67,000-square-foot Carlsbad, CA cGMP site will accelerate commercialization of plasmid-based medicines and vaccines.Contract Pharma Staff 12.17.20
-
APIs | Breaking News | Clinical Trial Materials | Facilities | Industry News
Recipharm Expands API Manufacturing Capabilities
Invests $2.5 million in clinical GMP capacity for APIs at Israel facility.Contract Pharma Staff 12.09.20
-
APIs | Clinical Trial Materials | Process Validation | QA/QC | Regulatory Affairs
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
AC Immune and WuXi Biologics Expand Strategic Partnership
Plan to accelerate AC Immune’s TDP-43 antibody into clinical development.Contract Pharma Staff 11.10.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News | Scale-up/Technology Transfer
Catalent, BrainStorm Enter ALS Drug Manufacturing Pact
Catalent will undertake the transfer of the manufacturing process to, and provide future cGMP clinical supply of NurOwn from its Houston facility.Contract Pharma Staff 10.22.20
-
Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
Greenwich Lifesciences Completes Manufacturing of GP2
The active ingredient is ready for its planned Phase III clinical trial.Contract Pharma Staff 10.13.20
-
Bio News | Breaking News | cGMP Manufacture | Clinical Trial Materials | Facilities | Industry News
Abzena Invests $60M Into cGMP Manufacturing Capacity
New facility in San Diego houses a process development laboratory and two new cGMP manufacturing cleanrooms.Contract Pharma Staff 10.08.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
Rentschler Biopharma Enters COVID-19 Vax Agreement with BioNTech
Will serve as CDMO partner for drug substance manufacturing of BNT162b2.Contract Pharma Staff 10.08.20
-
Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News | Preclinical Outsourcing
Ocugen Engages Kemwell Biopharma for cGMP Manufacture of OCU200
Paves the way towards getting OCU200 in the clinic by first half of 2022.Contract Pharma Staff 10.06.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Cobra Biologics to Manufacture Plasmids for COVID-19 Vax Trial
Collaboration will ensure GMP production of material for Phase I clinical trial of Scancell’s DNA vaccine against SARS-CoV-2.Contract Pharma Staff 10.05.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Fill/Finish | Industry News
Novavax, Par Sterile Products Enter COVID-19 Vax Mfg. Pact
Par Sterile's Rochester facility began production of NVX-CoV2373 final drug product, with initial batches to be used in Novavax' Phase III trial.Contract Pharma Staff 09.25.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News | Scale-up/Technology Transfer
T-knife, Catalent Sign Tech Transfer and Mfg. Pact for Cell Therapy
Catalent to provide technology transfer and cGMP clinical manufacture of T-knife’s T1367 T-cell receptor program at its site in Gosselies, Belgium.Contract Pharma Staff 09.21.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News | Process Development
Samsung Biologics Inks Service Pact with Panolos Bioscience
Will provide cell line development, process development, and clinical material manufacturing for PB101, an Fc-fusion protein to treat solid tumors.Contract Pharma Staff 09.17.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Takeda Opens R&D Cell Therapy Mfg. Facility in Boston
Will support expansion of next-generation clinical programs, including five collaborative oncology cell therapy programs entering trials.Contract Pharma Staff 09.15.20
-
Bio News | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
CMAB Biopharma and Laekna Therapeutics Collaborate
Enter strategic agreement for LAE005 global development and commercialization partnership.Contract Pharma Staff 09.10.20
